Andreas Varkaris, MD, PhD, discusses PIK3CA mutations in breast cancer and the novel therapies being developed to treat these tumors.
Andreas Varkaris, MD, PhD
Andreas Varkaris, MD, PhD, is an attending physician and investigator for the Termeer Center for Targeted Therapies at Massachusetts General Hospital.
Articles by Andreas Varkaris, MD, PhD